“The Text and Cultural Politics”: Michael Apple’s Enduring Contributions to Critical Education Research
AERA Open · 2026-01 · 12
DOI: 10.1177/23328584261458835 ↗Kurz gefasst
Fachartikel in der Zeitschrift AERA Open, online erschienen am 01.08.2026. Verfasst von Luis Armando Gandin. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This article examines Michael Apple’s theoretical contributions to the field of education, with particular attention to his epistemological principle of relational analysis, his understanding of the State as a site of contestation, his use of Gramscian concepts of hegemony and common sense, and his analysis of educational policy as cultural politics. Drawing on Apple’s foundational 1992 article, “The Text and Cultural Politics,” this article argues that Apple’s analytic tools remain indispensable for researchers seeking to understand how power operates in and through educational institutions. I demonstrate how Apple’s framework enables researchers to move beyond economistic determinism while retaining a commitment to structural analysis and critique and how it opens space for understanding agency and counterhegemony in educational practice. The article concludes by pointing to the ongoing relevance of Apple’s contributions for researchers engaged in critical educational policy studies today.
Zitieren
APA
Gandin, L. A. (2026). “The Text and Cultural Politics”: Michael Apple’s Enduring Contributions to Critical Education Research. AERA Open, 12. https://doi.org/10.1177/23328584261458835
Vancouver
Gandin LA. “The Text and Cultural Politics”: Michael Apple’s Enduring Contributions to Critical Education Research. AERA Open. 2026;12. doi:10.1177/23328584261458835
BibTeX
@article{Gandin2026,
author = {Gandin, Luis Armando},
title = {“The Text and Cultural Politics”: Michael Apple’s Enduring Contributions to Critical Education Research},
journal = {AERA Open},
year = {2026},
volume = {12},
doi = {10.1177/23328584261458835}
}
EUVIMED